Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Transcode Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2023 4 Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Bought 98,000 shares @ $0.51, valued at $50k
05/19/2023 4 Manting Erik (Director) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 45,000 options to buy @ $0.2834, valued at $12.8k
05/19/2023 4 Marquet Magda (Director) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 45,000 options to buy @ $0.2834, valued at $12.8k
05/19/2023 4 Fitzgerald Thomas A (CFO) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 300,000 options to buy @ $0.2834, valued at $85k
05/19/2023 4 Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 735,000 options to buy @ $0.2834, valued at $208.3k
05/19/2023 4 Calais Philippe (Director) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 45,000 options to buy @ $0.2834, valued at $12.8k
05/10/2023 4 Manting Erik (Director) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 9,500 options to buy @ $0.2985, valued at $2.8k
05/10/2023 4 Marquet Magda (Director) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 9,500 options to buy @ $0.2985, valued at $2.8k
05/10/2023 4 Calais Philippe (Director) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 9,500 options to buy @ $0.2985, valued at $2.8k
12/14/2022 4 Fitzgerald Thomas A (CFO) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $0.51, valued at $51k
12/14/2022 4 Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 135,000 options to buy @ $0.51, valued at $68.9k
12/14/2022 4 Medarova Zdravka (Chief Technology Officer) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 60,000 options to buy @ $0.561, valued at $33.7k
12/14/2022 4 Medarova Zdravka (Chief Technology Officer) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 33,000 options to buy @ $2.45, valued at $80.9k
09/16/2022 4 Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Bought 20,000 shares @ $1.15, valued at $23k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Fitzgerald Thomas A (CFO) has filed a Form 4 on Transcode Therapeutics, Inc.
Txns: Granted 52,000 options to buy @ $2.12, valued at $110.2k
07/08/2021 3 Dudley Robert Michael (CEO) has filed a Form 3 on Transcode Therapeutics, Inc.
07/08/2021 3 Fitzgerald Thomas A (VP, CFO) has filed a Form 3 on Transcode Therapeutics, Inc.
07/08/2021 3 Medarova Zdravka (10% Owner) has filed a Form 3 on Transcode Therapeutics, Inc.
07/08/2021 3 Manting Erik (Director) has filed a Form 3 on Transcode Therapeutics, Inc.
07/08/2021 3 Calais Philippe (Director) has filed a Form 3 on Transcode Therapeutics, Inc.
07/08/2021 3 Moore Anna (10% Owner) has filed a Form 3 on Transcode Therapeutics, Inc.
07/08/2021 3 Marquet Magda (Director) has filed a Form 3 on Transcode Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy